BEVERLY, Mass., March 19 /PRNewswire/ -- Insulet Corporation, a leading developer of disposable insulin delivery systems for the treatment of diabetes, today announced the addition of former Medtronic MiniMed executive Luis Malave as the company's new Vice President of Research and Development.
As part of Insulet's
senior management team, Malave
will oversee continued development of the company's patented Infuzor(TM) Insulin Infusion System, as well as all other internal and external research and development activities.
With a total of 16 years of experience in the medical device industry, Malave
spent approximately eight years in senior-level positions with Insulin delivery system leader, Medtronic
tenure at the company, Malave
was responsible for a broad range of market-impacting projects, including the software and systems re-development of several insulin infusion pump systems.Malave's
design, development and overall management of the Medtronic
MiniMed 508 Pump enabled the company to sell the largest number of any insulin infusion pumps on the marketplace today -- approximately 60,000 total worldwide. "A noted expert in the field of medical device systems for the diabetes marketplace, Luis represents a tremendous addition to Insulet's executive management team," said Duane Mason, Insulet co-founder, board member and founding general partner, Prism Venture Partners.
..."The simplicity and affordability of Insulet's infusion pump system will fundamentally change the way diabetes patients treat their disease," said Luis Malave, VP of R&D, Insulet.
"Insulet's breakthrough technology will also provide millions of individuals with the latest in affordable and accessible diabetes management devices."
About the Infuzor(TM) Insulet's
patented disposable insulin delivery system is a business-card sized patch that attaches to a patient's abdomen.Insulin injections are fed through a small needle and can be regulated through a wireless remote control system.